Assessing Blood Vessel Function in Heart Issues

A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices

Recruiting Observational Study
Acute Coronary Syndromes Flow Mediated Dilation Endothelial Function (FMD)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Aristotle University Of Thessaloniki · Other
Who this trial is looking for

This trial is looking for patients who have been hospitalized due to acute coronary syndrome, which includes certain types of heart attacks. Participants will undergo tests to evaluate blood vessel function and other heart-related measures.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am over 18 years old.
  • I have been hospitalized due to acute coronary syndrome.
  • I can provide written consent.
  • I can follow the study's schedule.

You may not be able to join if

  • I have a type of heart attack known as MINOCA.
  • I have rare types of heart syndrome like spontaneous coronary artery dissection.
  • I have congenital heart disease.
  • I am over 85 years old.
  • I have end stage chronic kidney disease.
  • I have an active cancer or autoimmune disease that limits my survival.
  • I am expected to live less than a year for any reason.
  • I am pregnant.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

A prospective, single-center, observational study aiming to assess the predictive role of flow mediated dilatation in acute coronary syndromes, combined with echocardiographic and biochemical indices. The novel Cor-IS technology will also be evaluated.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age \> 18 years 2. Patients hospitalized due to acute coronary syndrome (STEMI, NSTEMI) 3. Capability of providing written informed consent 4. Patients able to comply with the follow-up schedule of the study Exclusion Criteria: 1. Patients with acute coronary syndromes clas…
Contacts

Christodoulos E. Papadopoulos, PhD

2313312343

chrpapado@gmail.com

CONTACT

Georgios Zormpas, MD

2313312343

sparky.zorb@gmail.com

CONTACT